Oosterwijk E - Search Results

1

High energy shock waves induced increase in the local concentration of systemically given TNF-alpha.

Cornel EB, Oosterwijk E, van de Streek JD, Grutters G, Debruyne FM, Schalken JA, Oosterhof GO. Cornel EB, et al. Among authors: oosterwijk e. J Urol. 1994 Dec;152(6 Pt 1):2164-6. doi: 10.1016/s0022-5347(17)32344-3. J Urol. 1994. PMID: 7966708

2

Internal image anti-idiotype antibodies related to renal-cell carcinoma-associated antigen G250.

Uemura H, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Feb 15;56(4):609-14. doi: 10.1002/ijc.2910560424. Int J Cancer. 1994. PMID: 7509324

3

Radiolabeled monoclonal antibody G250 in renal-cell carcinoma.

Oosterwijk E, Debruyne FM. Oosterwijk E, et al. World J Urol. 1995;13(3):186-90. doi: 10.1007/BF00184877. World J Urol. 1995. PMID: 7550393 Free article. Clinical Trial.

4

The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma.

Oosterwijk E, Debruyne FM, Schalken JA. Oosterwijk E, et al. Semin Oncol. 1995 Feb;22(1):34-41. Semin Oncol. 1995. PMID: 7855618 Review. No abstract available.

5

Immunization with anti-idiotype monoclonal antibodies bearing the internal image of the renal-cell carcinoma-associated antigen G250 induces specific cellular immune responses.

Uemura H, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Dec 15;59(6):802-7. doi: 10.1002/ijc.2910590616. Int J Cancer. 1994. PMID: 7989122

6

Vaccination with anti-idiotype antibodies mimicking a renal cell carcinoma-associated antigen induces tumor immunity.

Uemura H, Beniers AJ, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Aug 15;58(4):555-61. doi: 10.1002/ijc.2910580418. Int J Cancer. 1994. PMID: 8056452

7

Complex cadherin expression in renal cell carcinoma.

Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Cancer Res. 1996 Jul 15;56(14):3234-7. Cancer Res. 1996. PMID: 8764114

8

Molecular prognostic factor in renal cell carcinoma.

Shimazui T, Oosterwijk E, Debruyne FM, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Semin Urol Oncol. 1996 Nov;14(4):250-5. Semin Urol Oncol. 1996. PMID: 8946626 Review.

9

Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.

Steffens MG, Boerman OC, Oosterwijk-Wakka JC, Oosterhof GO, Witjes JA, Koenders EB, Oyen WJ, Buijs WC, Debruyne FM, Corstens FH, Oosterwijk E. Steffens MG, et al. Among authors: oosterwijk e, oosterwijk wakka jc. J Clin Oncol. 1997 Apr;15(4):1529-37. doi: 10.1200/JCO.1997.15.4.1529. J Clin Oncol. 1997. PMID: 9193349 Free article. Clinical Trial.

10

Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinoma.

Shimazui T, Bringuier PP, van Berkel H, Ruijter E, Akaza H, Debruyne FM, Oosterwijk E, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Int J Cancer. 1997 Oct 21;74(5):523-8. doi: 10.1002/(sici)1097-0215(19971021)74:5<523::aid-ijc8>3.0.co;2-5. Int J Cancer. 1997. PMID: 9355975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters